• Nenhum resultado encontrado

structure-based drug design

Structure-based drug design studies of the interactions of ent-kaurane diterpenes derived from Wedelia paludosa with the Plasmodium

Structure-based drug design studies of the interactions of ent-kaurane diterpenes derived from Wedelia paludosa with the Plasmodium

... tive modelling using the three-dimensional structure of a homologous protein, 1IWO, as a scaffold. Compound 21 showed the best docking scores, indicating a better interaction with PfATP6 than that of thapsigargin, ...

6

Structure based drug design for the discovery of promising inhibitors of human Bcl-2 and Streptococcus

Structure based drug design for the discovery of promising inhibitors of human Bcl-2 and Streptococcus

... Once the target has been identified, its implications on the disease phenotype must be validated through in vitro techniques. One of the methodologies to validate a target is using antisense technology, in which RNA-like ...

149

Computational drug discovery for the Zika virus

Computational drug discovery for the Zika virus

... Structure-based drug design (SBDD) is a very useful approach when the biological target is known, and its 3D structure is ...available. Based on the target 3D structural ...

10

Drug design for ever, from hype to hope

Drug design for ever, from hype to hope

... called structure-based drug design has never looked so clear and promising as at that particular moment in ...ligand structure (determined by NMR or X-ray), the measured binding ...

14

An integrated in silico approach to design specific inhibitors targeting human poly(a)-specific ribonuclease.

An integrated in silico approach to design specific inhibitors targeting human poly(a)-specific ribonuclease.

... complete structure of the full-length human PARN, as well as several aspects of the catalytic mechanism still remain elusive, many previous studies indicate that PARN can be used as potent and promising ...

13

Unbalance Quantitative Structure Activity Relationship Problem Reduction in Drug Design

Unbalance Quantitative Structure Activity Relationship Problem Reduction in Drug Design

... is based on the statistical learning theory and the Vapnik- Chervonenkis (VC) dimension introduced by Vladimir Vapnik and Alexey ..., drug discovery [6,8] ...

9

A relational learning approach to Structure-Activity Relationships in drug design toxicity studies.

A relational learning approach to Structure-Activity Relationships in drug design toxicity studies.

... To be more precise, the iLogCHEM algorithm is an extension of the greedy cover algorithm with ILP’s Mode Directed Inverse Entailment algorithm (MDIE) [21]. The first implementa- tion of this algorithm was the Progol ...

19

Recent Advances and Perspectives in Cancer Drug Design

Recent Advances and Perspectives in Cancer Drug Design

... establish structure-activity relationships (SAR) among the designed ...molecular design and optimization. These methods are divided into structure- and ligand-based drug design ...

18

Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors

Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors

... rigid structure and restricted binding when compared to ...WT structure, no meaningful interactions between F18 and the binding pocket residues were ...WT structure is more sensitive to NVP than to ...

18

Affinity improvement of a therapeutic antibody by structure-based computational design: generation of electrostatic interactions in the transition state stabilizes the antibody-antigen complex.

Affinity improvement of a therapeutic antibody by structure-based computational design: generation of electrostatic interactions in the transition state stabilizes the antibody-antigen complex.

... The exquisite specificity and high affinity of antibodies are increasingly exploited for therapeutic and biotechnological pur- poses, such as in cancer immunotherapy, in diagnosis, and in molecular bio-sensors [1–3]. ...

9

Guide to build YOLO, a creativity-stimulating robot for children

Guide to build YOLO, a creativity-stimulating robot for children

... The field of HRI is characterized by multidisciplinarity, for which the open access to research tools, such as robots’ hard- ware and software, is crucial [34]. YOLO presents as a low-purchase and low-maintenance cost ...

15

Prediction of drug-target interactions for drug repositioning only based on genomic expression similarity.

Prediction of drug-target interactions for drug repositioning only based on genomic expression similarity.

... For instance, the designated ligands of neurotransmitter receptors generally showed high LOI to the cardiac ion channels (Figure 7B). Cardiac ion channels, present in the membranes of cardiac cells, control the movement ...

9

Using Universal Design for Learning to Design Standards-Based Lessons

Using Universal Design for Learning to Design Standards-Based Lessons

... can design a lesson in which students have the choice to develop their narratives in various formats as they work toward ultimately creating a written ...ways, based on their objectives for a lesson and for ...

12

Molecular modeling: a tool for rational drug design in medicinal chemistry.

Molecular modeling: a tool for rational drug design in medicinal chemistry.

... Expressões como CADD (Computer Aided Drug Design, desenho de drogas assistido computacionalmente), entre outras, foram recentemente incorporadas à linguagem da Química Me- dicinal. Trata-se de uma ...

11

A single acidic residue can guide binding site selection but does not govern QacR cationic-drug affinity.

A single acidic residue can guide binding site selection but does not govern QacR cationic-drug affinity.

... Collectively, these data indicate that, in direct contrast to the multidrug-binding proteins EmrE, QacA, LmrP, AcrR and BmrR, for which acidic residues have been shown to provide a direct and significant energetic ...

10

Rational Structure-Based Rescaffolding Approach to De Novo Design of Interleukin 10 (IL-10) Receptor-1 Mimetics.

Rational Structure-Based Rescaffolding Approach to De Novo Design of Interleukin 10 (IL-10) Receptor-1 Mimetics.

... rational design of molecules that disrupt PPIs is particularly challenging due to the large and structurally complex nature of the interfaces ...secondary structure of protein-protein interfaces [12–14] do ...

25

New chromene-based drug candidates for cancer treatment

New chromene-based drug candidates for cancer treatment

... the structure quite simple and making possible the interaction of the ethoxy oxygen atom, forming an additional hydrogen bond with residues of Try867 and Asp964 in the hydrophobic pocket observed by molecular ...

115

Analysis and Design of Marine Berthing Structure

Analysis and Design of Marine Berthing Structure

... Berthing territory ought to be focused around the length and broadness of the biggest size of boat utilizing for the berths. Berthing range is the zone before the berthing structure needed for berthing vessels ...

11

Prediction of drug-target interactions and drug repositioning via network-based inference.

Prediction of drug-target interactions and drug repositioning via network-based inference.

... is based on chemical 2D structural similarity, and TBSI is based on genomic sequence similarity, whereas NBI is only based on DT bipartite network topology similarity (Figure ...prediction ...

12

Braz. oral res.  vol.25 número4

Braz. oral res. vol.25 número4

... coronal structure and with different inish ...coronal structure, and with a beveled shoulder, a bevel, or a shoulder inish line ...coronal structure showed the highest fracture strength values when ...

6

Show all 10000 documents...

temas relacionados